Publicacións nas que colabora con Juan Carlos Prieto Villapún (11)

2005

  1. Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K

    Prostate, Vol. 63, Núm. 1, pp. 44-55

2004

  1. Effects of the antiandrogen flutamide on the expression of protein kinase C isoenzymes in LNCaP and PC3 human prostate cancer cells

    Bioscience Reports, Vol. 24, Núm. 1, pp. 11-21

  2. Vasoactive intestinal peptide increases vascular endothelial growth factor expression and neuroendocrine differentiation in human prostate cancer LNCaP cells

    Regulatory Peptides, Vol. 119, Núm. 1-2, pp. 69-75

2003

  1. VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal

    British Journal of Pharmacology, Vol. 139, Núm. 5, pp. 1050-1058

2001

  1. Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors

    Cellular Signalling, Vol. 13, Núm. 12, pp. 887-894

1998

  1. Cyclosporin A induces apoptosis in rat hepatocytes in culture

    Archives of Toxicology, Vol. 72, Núm. 9, pp. 559-565

  2. Inhibitory effect of cyclosporin A peptide on rat hepatocytes proliferation induced by mitogens

    Peptides, Vol. 19, Núm. 3, pp. 427-435

1995

  1. Receptors for pituitary adenylate cyclase-activating peptide in human liver

    Journal of Clinical Endocrinology and Metabolism, Vol. 80, Núm. 8, pp. 2451-2457

1994

  1. Characterization of vasoactive intestinal peptide receptors in human liver

    BBA - Molecular Cell Research, Vol. 1221, Núm. 2, pp. 193-198

  2. G proteins in rat liver proliferation during cholestasis

    Hepatology, Vol. 20, Núm. 4, pp. 1041-1047

1992

  1. Vasoactive intestinal peptide receptors in rat liver after partial hepatectomy

    Biochemical Journal, Vol. 285, Núm. 2, pp. 515-520